COMMUNIQUÉS West-GlobeNewswire

NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
06/02/2024
Criteria Change Reduces Requirements for Treatment Accessibility MALVERN, Pa., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and [...]
Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors
06/02/2024
Deepens leadership team with decades of experience across animal and human health Brings strategic vision to drive next stages of growth SAN DIEGO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Gallant Therapeutics , an animal [...]
BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market
06/02/2024
MELVILEE, N.Y., Feb. 06, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced it has [...]
Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
06/02/2024
Company opens own physician-led laboratory, ‘European Oncology Lab’ (EOL), thereby offering ColoAlert® as a laboratory medical service directly to physicians and patients BERKELEY, Calif. and MAINZ, Germany, Feb. 06, [...]
Aprea Therapeutics Announces Submission of IND Application for APR-1051, a Next Generation WEE1 Kinase Inhibitor
06/02/2024
DOYLESTOWN, Pa., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology through synthetic [...]
Ultragenyx Announces Data Demonstrating Treatment with UX111 Results in Significant Reduction in Heparan Sulfate Exposure in Cerebrospinal Fluid Correlated with Improved Long-term Cognitive Function in Patients with Sanfilippo Syndrome Type A (MPS IIIA)
06/02/2024
The latest data from the pivotal Transpher A and long-term follow-up studies will be presented at WORLDSymposium™ 2024 NOVATO, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) [...]
Cancer and Blood Specialists of Georgia Opens New Oncology Clinic in Cumming
06/02/2024
The community oncology practice is equipped to treat a wide variety of cancer types and is open to both new and current patients. CUMMING, Ga., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cancer and Blood Specialists of Georgia [...]
Fulcrum Therapeutics to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
06/02/2024
CAMBRIDGE, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
06/02/2024
NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company developing medicines designed to conquer epilepsies and meaningfully improve the lives of people affected by [...]
NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open Today
06/02/2024
DURHAM, N.C., Feb. 06, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences / Scorpius Holdings, Inc. (NYSE American: NHWK ; SCPX) , an integrated contract development and manufacturing organization (CDMO), today announced [...]
Alignment Healthcare to Announce Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call Tuesday, Feb. 27, 2024
06/02/2024
ORANGE, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its fourth quarter and full-year 2023 financial results on Tuesday, Feb. 27, after market close. Following the [...]
New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss
06/02/2024
SOUTH SAN FRANCISCO, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today [...]
electroCore Expands Intellectual Property Portfolio
06/02/2024
ROCKAWAY, N.J., Feb. 06, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Trademark Office has [...]
Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer
06/02/2024
-- Vepdegestrant is an investigational PROteolysis Targeting Chimera (PROTAC ® ) protein degrader designed to target and degrade the estrogen receptor (ER) protein -- NEW HAVEN, Conn. and NEW YORK, Feb. 06, 2024 (GLOBE [...]
PEAR Health Labs partners with Google Cloud to enhance personalized fitness experience with generative AI
06/02/2024
Two leading artificial intelligence companies collaborate to lower barriers to accessing personalized health and fitness recommendations with a more approachable, interactive digital interface SOLANA BEACH, Calif., Feb [...]
Curium Announces Ioflupane I 123 Injection Availability for Friday Patient Use
06/02/2024
ST. LOUIS, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that beginning Friday, April 5, 2024, Ioflupane I 123 Injection will be available for Friday patient [...]
Novo Nordisk A/S - share repurchase programme
06/02/2024
Bagsværd, Denmark, 6 February 2024 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2024 of DKK 20 billion will be initiated on 6 February 2024. As part of this, Novo Nordisk A/S has now [...]
Nicox announces presentations at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024
06/02/2024
Press Release Nicox announces presentations at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024 February 6, 2024 – release at 7:30 am CET Sophia Antipolis, France Nicox SA ( [...]
Nicox : Présentations au prochain Congrès Annuel 2024 de l’Association for Research in Vision and Ophthalmology (ARVO)
06/02/2024
Communiqué de presse Nicox : Présentations au prochain Congrès Annuel 2024 de l’Association for Research in Vision and Ophthalmology (ARVO) 6 février 2024 – diffusion à 7h30 Sophia Antipolis, France Nicox SA (Euronext [...]

Pages